other material
confidence high
sentiment neutral
materiality 0.55
Humacyte prices $15M registered direct offering of common stock and warrants at $5.34/unit
Humacyte, Inc.
- Pricing of 2,808,988 shares and warrants to purchase up to 2,808,988 shares at $5.34 per unit on Nov 14, 2024.
- Gross proceeds of approximately $15M before expenses; closing expected on or about Nov 15, 2024.
- Warrants split: 1,404,494 expire in 180 days; 1,404,494 expire in four and one-half years, both at $5.34 exercise.
- Company agrees to no further equity issuance or variable rate transactions until FDA approval for extremity vascular trauma or 30 days.